Journals / Okmeydanı Tıp Dergisi / 2015 / Cilt: 31 - Sayı: 0

Diabetes Mellitus and ENT

Diabetes Mellitus ve Kulak-Burun-Boğaz

Pages
7–11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For this reason diabetic patients should be followed closely and regulation of blood sugar should be achieved by following with the laboratory tests

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetes mellitus, may predispose to important ENT disorders by showing degenerative effects to neurovascular structures.
📊
Key Findings & Data:Malignant otitis externa, sudden hearing loss, progressive hearing loss, peripheral vertigo, mucormycosis, xerostomia are the main diseases that can be considered.
💡
Conclusion & Impact:For this reason diabetic patients should be followed closely and regulation of blood sugar should be achieved by following with the laboratory tests
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diabetes mellitus, may predispose to important ENT disorders by showing degenerative effects to neurovascular structures. Malignant otitis externa, sudden hearing loss, progressive hearing loss, peripheral vertigo, mucormycosis, xerostomia are the main diseases that can be considered. Additionally, it may cause complications in surgical treatment either by causing delay in wound healing, or medical treatment with corticosteroids. For this reason diabetic patients should be followed closely and regulation of blood sugar should be achieved by following with the laboratory tests

Özet

Diabetes mellitus, nörovasküler yapılar üzerinde dejeneratif etki göstererek önemli kulak burun boğaz hastalıklarına neden olabilmektedir. Malign otitis eksterna, ani işitme kaybı, ilerleyici işitme kaybı, periferik vertigo, mukormukozis, kserostomi etiyolojisinde gösterilen başlıca sayılabilecek hastalıklardır. Ayrıca hem kortikosteroid ile yapılan medikal tedavilerde hem de yara iyileşmesinde gecikme ile cerrahi yönden komplikasyonlara neden olmaktadır. Diyabetik olanlar bu nedenle yakından takip edilmeli, laboratuvar testleri ile takip edilerek kan şekeri regülasyonu sağlanmalıdır

🔖

Cite This Article

ATAR, Y., AYDOĞDU, İ., SALTÜRK, Z., KUMRAL, T. L., UYAR, Y. (2015). Diabetes Mellitus and ENT. Okmeydanı Tıp Dergisi, Cilt: 31 - Sayı: 0, 7–11. https://ajindex.com/articles/291784

References (10)

  1. Fukushima H, Cureoglu S, Schachern PA et al. Effects of type 2 diabetes mellitus on cochlear structure in hu- mans. Arch Otolaryngol Head Neck Surg 2006;132: 934-938. http://dx.doi.org/10.1001/archotol.132.9.934
  2. Edwards JE, Tillman DB, Miller ME, Pitchon PE. In- fection and diabetes mellitus. West J Med 1979;130: 515-521.
  3. Larkin JG, Frier BM, Ireland JT. Diabetes mellitus and infection. Postgrad Med J 1985;61:233-237. http://dx.doi.org/10.1136/pgmj.61.713.233 Chávez-Delgado ME1, Vázquez-Granados I, Rosales- Cortés M, Velasco-Rodríguez V. Cochleovestibular dysfunction in patients with diabetes mellitus, hyper- tension and dyslipidemia. Acta Otorrinolaringol Esp 2012;63:93-101. http://dx.doi.org/10.1016/j.otoeng.2012.03.012
  4. Horikawa C, Kodama S, Tanaka S et al. Diabetes and risk of hearing impairment in adults: a meta-analysis. J Clin Endocrinol Metab 2013;98:51-58. http://dx.doi.org/10.1210/jc.2012-2119 Klagenberg KF1, Zeigelboim BS, Jurkiewicz AL, Martins-Bassetto J. Vestibulocochlear manifestations in patients with type I diabetes mellitus. Braz J Otorhi- nolaryngol 2007;73:353-358. Çelik O. Kulak Burun Boğaz Hastalıkları ve Baş Boyun Cerrahisi. Birinci Baskı. İstanbul: Güneş Tıp Kitapevi 2004;71-87.
  5. Akyol MU, Öğretmenoğlu O, Hoşal Ş ve ark. Diyabetik hastalarda görülen fasiyal paralizilerin tedavisinde ste- roid kullanımı. Kulak Burun Bogaz İhtis Derg 1995;3: 213-216.
  6. Lin SW, Lin YS, Weng SF, Chou CW. Risk of develo- ping sudden sensorineural hearing loss in diabetic pa- tients: a population-based cohort study. Otol Neurotol 2012;33:1482-1488. http://dx.doi.org/10.1097/MAO.0b013e318271397a
  7. Oladeji S, Amusa Y, Olabanji J, Adisa A. Rhinocerebral mucormycosis in a diabetic case report. J West Afr Coll Surg 2013;3:93-102.
  8. Ahn JH, Kim TY, Kim YJ et al. Lipo-prostaglandin E1 in combination with steroid therapy is effective for treatment of sudden sensorineural hearing loss in Korean patients with Type 2 diabetes. Diabet Med 2006;23:1339-1343. http://dx.doi.org/10.1111/j.1464-5491.2006.01993.x
  9. Maia CA, Campos CA. Diabetes mellitus as etiological factor of hearing loss. Braz J Otorhinolaryngol 2005; 71:208-214.
  10. Gibrin PC, Melo JJ, Marchiori LL. Prevalence of tin- nitus complaints and probable association with hearing loss, diabetes mellitus and hypertension in elderly. Co- das 2013;25:176-180. http://dx.doi.org/10.1590/S2317-17822013000200014 Marsot-Dupuch K. Pulsatile and nonpulsatile tinnitus: a systemic approach. Semin Ultrasound CT MR 2001;22: 250-270. http: